us en false false Default
Skip directly to Accessibility Notice
PPH VanEck Pharmaceutical ETF Please read important disclosure Close important disclosure false

PPH
VanEck Pharmaceutical ETF

PPH
VanEck Pharmaceutical ETF

  • NAV
    $106.14

    as of February 03, 2026
  • YTD RETURNS
    2.92%

    as of February 03, 2026
  • Total Net Assets
    $1.15B

    as of February 03, 2026
  • Total Expense Ratio
    0.36%
  • Inception Date
    12/20/2011

About PPH

VanEck Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

Buy Now
Let's Connect
Subscribe

Overview

Why PPH

  • Highly Liquid Companies: Tracks the largest most liquid pharmaceutical companies
  • Industry Leaders: Favors established industry leaders with meaningful scale
  • Global Scope: Provides exposure to U.S. and international equities for global industry representation  

Performance

Performance History:

Average Annual Total Returns* (%)

View All ETFs View All Indices
  1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
12/20/11
PPH (NAV) 0.86 14.97 21.92 21.92 12.11 11.34 6.74 10.00
PPH (Share Price) 0.95 15.00 22.03 22.03 12.14 11.34 6.73 10.08
MVPPHTR (Index) 0.89 15.01 21.58 21.58 11.64 10.88 6.49 9.81
Performance Differential (NAV - Index) -0.03 -0.04 0.34 0.34 0.47 0.46 0.25 0.19
  1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
12/20/11
PPH (NAV) 0.86 14.97 21.92 21.92 12.11 11.34 6.74 10.00
PPH (Share Price) 0.95 15.00 22.03 22.03 12.14 11.34 6.73 10.08
MVPPHTR (Index) 0.89 15.01 21.58 21.58 11.64 10.88 6.49 9.81
Performance Differential (NAV - Index) -0.03 -0.04 0.34 0.34 0.47 0.46 0.25 0.19

*Returns less than one year are not annualized.

The performance data quoted represents past performance. Past performance is not a guarantee of future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Performance may be lower or higher than performance data quoted. Please call 800.826.2333 or visit vaneck.com for performance current to the most recent month ended.

Prices as of 02/03/2026

NAV/
Market
Price 		Volume
30-Day Avg./
Last Trading Day 		Daily Change
NAV/
Last Price 		YTD Change NAV/
Last Price 		Premium/
Discount 		30-Day
Median
Bid Ask
Spread 		NAV
Chart
PPH $106.14
$106.12 		431,998
837,437 		$-1.97 / -1.82%
$-2.01 / -1.86% 		+2.92%
+2.86% 		$-0.02
-0.01% 		0.03%

Fees

Holdings

Daily Holdings (%) as of 02/02/2026

Download XLS Get holdings
Total Holdings: 27
Ticker
 Holding Name % of Net
Assets
Identifier (FIGI)
Shares
 Asset Class Market Value
(US$) 		Notional Value
LLY US
 Eli Lilly & Co 19.27
BBG000BNBDC2
215,202
 Stock 224,698,864 --
NVS US
 Novartis Ag 10.49
BBG000LYF3S8
810,299
 Stock 122,387,561 --
MRK US
 Merck & Co Inc 9.14
BBG000BPD168
940,600
 Stock 106,635,822 --
NVO US
 Novo Nordisk A/S 7.12
BBG000BQBKR3
1,410,082
 Stock 83,096,132 --
PFE US
 Pfizer Inc 4.74
BBG000BR2B91
2,073,614
 Stock 55,282,549 --
JNJ US
 Johnson & Johnson 4.61
BBG000BMHYD1
232,942
 Stock 53,751,367 --
BMY US
 Bristol-Myers Squibb Co 4.50
BBG000DQLV23
939,506
 Stock 52,508,990 --
GSK US
 Gsk Plc 4.47
BBG000BLB481
993,843
 Stock 52,146,942 --
MCK US
 Mckesson Corp 4.29
BBG000DYGNW7
59,170
 Stock 50,087,997 --
AZN US
 Astrazeneca Plc 4.25
--
262,794
 Stock 49,513,018 --
9996651D US
 Astrazeneca Plc 4.25
BBG000BZ0DK8
262,794
 Stock 49,513,018 --
ABBV US
 Abbvie Inc 4.13
BBG0025Y4RY4
213,662
 Stock 48,210,694 --
COR US
 Cencora Inc 4.07
BBG000MDCQC2
130,573
 Stock 47,471,120 --
SNY US
 Sanofi Sa/France 4.04
BBG000BBD5N1
996,934
 Stock 47,125,070 --
ZTS US
 Zoetis Inc 3.30
BBG0039320N9
307,879
 Stock 38,466,402 --
HLN US
 Haleon Plc 2.99
BBG018GZNCH6
3,300,851
 Stock 34,856,987 --
TEVA US
 Teva Pharmaceutical Industries Ltd 2.83
BBG000C0CD58
928,232
 Stock 32,970,801 --
TAK US
 Takeda Pharmaceutical Co Ltd 2.76
BBG000LF8708
1,843,469
 Stock 32,242,273 --
VTRS US
 Viatris Inc 0.78
BBG00Y4RQNH4
667,276
 Stock 9,128,336 --
JAZZ US
 Jazz Pharmaceuticals Plc 0.59
BBG000G9CGL0
41,418
 Stock 6,928,817 --
AXSM US
 Axsome Therapeutics Inc 0.48
BBG00B6G7GL7
30,064
 Stock 5,588,296 --
ELAN US
 Elanco Animal Health Inc 0.45
BBG00LJYS1P8
211,660
 Stock 5,238,585 --
CORT US
 Corcept Therapeutics Inc 0.19
BBG000BKJG33
54,667
 Stock 2,225,494 --
OGN US
 Organon & Co 0.12
BBG00ZQRGW24
168,340
 Stock 1,380,388 --
BHC US
 Bausch Health Cos Inc 0.09
BBG000DLFM21
176,937
 Stock 1,019,157 --
PRGO US
 Perrigo Co Plc 0.08
BBG000CNFQW6
68,006
 Stock 973,846 --
-USD CASH-
 0.01
--
66,121
 Cash Bal 66,121 --
--
Other/Cash -4.05
--
0
 Cash -47,231,269 --
← Scroll for more information →
These are not recommendations to buy or to sell any security. Securities and holdings may vary.

Portfolio

Sector Weightings (%) as at 12/31/2025

  • Sector

    % of Net Assets

  • Health Care

    99.93

  • Other/Cash

    0.07

Country Weightings (%) as at 12/31/2025

  • Country

    % of Net Assets

  • United States

    62.19

  • United Kingdom

    11.72

  • Switzerland

    10.04

  • Denmark

    6.45

  • France

    4.34

  • Israel

    2.60

  • Japan

    2.58

  • Other/Cash

    0.07

Distributions

Yields  as of  02/03/2026

Distribution Frequency

Quarterly

30-Day SEC Yield

1.85%

Distribution Yield

1.17%

12 Month Yield

1.73%

Yield information reflects temporary waivers of expenses and/or fees. Yields would have been reduced had these fees/expenses been included. In the absence of temporary expense waivers or reimbursements, the 30-Day SEC Yield for VanEck Pharmaceutical ETF would have been 1.85% on 02/03/26. Distributions may vary from time to time.

Team

Literature

PPH